SG170804A1 - Pseudomonas aeruginosa outer membrane protein pa0427 - Google Patents

Pseudomonas aeruginosa outer membrane protein pa0427

Info

Publication number
SG170804A1
SG170804A1 SG201102257-1A SG2011022571A SG170804A1 SG 170804 A1 SG170804 A1 SG 170804A1 SG 2011022571 A SG2011022571 A SG 2011022571A SG 170804 A1 SG170804 A1 SG 170804A1
Authority
SG
Singapore
Prior art keywords
pseudomonas aeruginosa
outer membrane
membrane protein
aeruginosa outer
protein
Prior art date
Application number
SG201102257-1A
Other languages
English (en)
Inventor
Jiro Tanaka
Fukuichi Ohsawa
Takafumi Okutomi
Hiroshi Nagaso
Masashi Kumagai
Takahisa Suzuki
Keiko Otsuka
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of SG170804A1 publication Critical patent/SG170804A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG201102257-1A 2006-03-30 2007-03-30 Pseudomonas aeruginosa outer membrane protein pa0427 SG170804A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006095996 2006-03-30

Publications (1)

Publication Number Publication Date
SG170804A1 true SG170804A1 (en) 2011-05-30

Family

ID=38563607

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201102257-1A SG170804A1 (en) 2006-03-30 2007-03-30 Pseudomonas aeruginosa outer membrane protein pa0427

Country Status (9)

Country Link
US (1) US8084044B2 (ko)
EP (1) EP2011867A4 (ko)
JP (1) JPWO2007114340A1 (ko)
KR (1) KR20080113239A (ko)
CN (1) CN101454446A (ko)
AU (1) AU2007232894B2 (ko)
CA (1) CA2645904A1 (ko)
SG (1) SG170804A1 (ko)
WO (1) WO2007114340A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080068048A (ko) * 2005-10-28 2008-07-22 메이지 세이카 가부시키가이샤 녹농균의 외막 단백질 ｐａ5158
JPWO2009081955A1 (ja) * 2007-12-25 2011-05-06 明治製菓株式会社 緑膿菌のｉｉｉ型分泌装置構成タンパク質ｐａ１６９８
US8501179B2 (en) 2008-01-10 2013-08-06 Shionogi & Co., Ltd. Antibody against PcrV
ES2529734T7 (es) 2009-03-11 2015-08-11 Shionogi & Co., Ltd. Anticuerpo PcrV humanizado con actividad anti-pseudomonas
EP2794639A4 (en) * 2011-12-20 2015-08-19 Merck Sharp & Dohme PSEUDOMONAS AERUGINOSA OPRM EPITOPES FOR USE IN DIAGNOSIS AND THERAPY
WO2017005670A1 (en) * 2015-07-04 2017-01-12 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
CN105424929B (zh) * 2015-11-24 2017-08-08 四川夹金山逢春养殖科技有限公司 一种铜绿假单胞菌抗体检测试剂盒及检测方法
CN105669844B (zh) * 2016-03-02 2019-11-08 中国人民解放军第三军医大学 一种铜绿假单胞菌重组蛋白Vac33的纯化方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
WO1985000372A1 (fr) 1983-07-01 1985-01-31 Battelle Memorial Institute Polypeptide biodegradable et son utilisation pour le relargage progressif de medicaments
US5417986A (en) 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
DK0463151T3 (da) 1990-01-12 1996-07-01 Cell Genesys Inc Frembringelse af xenogene antistoffer
DE69133476T2 (de) 1990-08-29 2006-01-05 GenPharm International, Inc., Palo Alto Transgene Mäuse fähig zur Produktion heterologer Antikörper
JPH11206387A (ja) 1991-08-28 1999-08-03 Genpharm Internatl Inc 異種免疫グロブリンを作る方法及びそのためのトランスジェニックマウス
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
CU22615A1 (es) 1994-06-30 2000-02-10 Centro Inmunologia Molecular Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
DE69515613T2 (de) 1994-12-16 2000-11-30 Chiron Behring Gmbh & Co Immunogenes Hybridprotein OprF-Oprl erhältlich aus Membranproteinen von Pseudomonas aeruginosa
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
ES2255329T3 (es) 1998-11-25 2006-06-16 Mcw Research Foundation, Inc. Metodo y composiciones para inmunizacion con el antigeno v de pseudomonas aeruginosa.
US20030228324A1 (en) 1999-05-06 2003-12-11 Malcolm Andrew J. Peptide compositions and methods of producing and using same
KR20080068048A (ko) 2005-10-28 2008-07-22 메이지 세이카 가부시키가이샤 녹농균의 외막 단백질 ｐａ5158

Also Published As

Publication number Publication date
KR20080113239A (ko) 2008-12-29
AU2007232894A1 (en) 2007-10-11
US8084044B2 (en) 2011-12-27
WO2007114340A1 (ja) 2007-10-11
US20090117121A1 (en) 2009-05-07
EP2011867A1 (en) 2009-01-07
AU2007232894B2 (en) 2013-01-31
CN101454446A (zh) 2009-06-10
EP2011867A4 (en) 2009-11-25
JPWO2007114340A1 (ja) 2009-08-20
CA2645904A1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
SG170804A1 (en) Pseudomonas aeruginosa outer membrane protein pa0427
NL301089I2 (nl) imlifidase
DOP2009000269A (es) Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos
MX2009004532A (es) Composiciones y metodos para unir esfingosina-1-fosfato.
WO2007056457A3 (en) Methods, compositions, and kits for the treatment of medical conditions
MX2007013626A (es) Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos.
CR10730A (es) Anticuerpos agonistas anti notch3 y su uso en el tratamiento de las enfermedades relacionadas con el gen notch3
MY181969A (en) Anti-n3pglu amyloid beta peptide antibodies and uses thereof
EA201000644A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
UA94221C2 (en) Lipocalin protein
WO2012021786A3 (en) Anti-hemagglutinin antibody compositions and methods of use thereof
GEP20115195B (en) Antibodies directed against amyloid-beta peptide and use thereof
TW201129378A (en) Materials and methods for treating or preventing HER-3 associated diseases
MX337081B (es) Anticuerpo anti-nr10 y su uso.
MY149630A (en) Antibodies against amyloid-beta peptide
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
WO2006086799A3 (en) Prion-specific peptide reagents
HK1243943A1 (zh) 使用抗IL-1α抗體治療癌症
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
UA109633C2 (uk) Антитіло людини проти тканинного фактора
WO2008071418A3 (en) Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases
JO3358B1 (ar) معالجات حساسية العيون
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
WO2007111661A3 (en) Human antibodies specific for gastrin materials and methods